Medtronic Plc
(NYSE : MDT)

( )
MDT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories -0.62%84.330.8%$1191.41m
MDTMedtronic Plc 0.01%99.210.6%$1000.67m
TMOThermo Fisher Scientific, Inc. -1.03%304.001.0%$906.66m
ISRGIntuitive Surgical, Inc. -0.90%505.912.4%$740.05m
DHRDanaher Corp. -1.35%143.070.7%$721.66m
BDXBecton, Dickinson & Co. 5.24%249.991.1%$694.59m
SYKStryker Corp. 0.62%177.801.3%$633.65m
BSXBoston Scientific Corp. 4.22%35.111.1%$534.75m
EWEdwards Lifesciences Corp. 6.30%206.991.2%$452.15m
DXCMDexCom, Inc. 2.91%258.018.2%$400.59m
BAXBaxter International, Inc. 2.35%84.451.8%$372.65m
ZBHZimmer Biomet Holdings, Inc. 9.17%111.251.7%$307.78m
ALGNAlign Technology, Inc. 5.65%184.416.4%$282.44m
IDXXIDEXX Laboratories, Inc. -0.64%253.103.8%$265.54m
INOInovio Pharmaceuticals, Inc. -1.20%8.226.8%$254.25m

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.